Chonyang L Albert1,2. 1. Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, Desk J3-4, Cleveland, OH, 44195, USA. albertc2@ccf.org. 2. Heart and Vascular Institute, Kaufman Center for Heart Failure, Cleveland Clinic, Cleveland, OH, USA. albertc2@ccf.org.
Abstract
PURPOSE OF REVIEW: This review will define morbid obesity and relationship between morbid obesity and heart failure syndromes. It will delve into unique challenges facing patients with dual diagnoses of heart failure and morbid obesity and examine the data that obesity should be a target in the treatment of heart failure. RECENT FINDINGS: Emerging literature has indicated the safety and efficacy of surgical weight loss in patients with heart failure. Furthermore, bariatric surgery with associated weight loss has been associated with improvements in heart failure symptoms and reverse remodeling on echocardiography. In patients with advanced heart failure, bariatric surgery has led to improvement in heart failure to obviate the need for cardiac transplantation or sufficient weight loss for cardiac transplant eligibility. In heart failure patients who are morbidly obese, treatment of obesity is an effective therapeutic target with a myriad of potential benefits.
PURPOSE OF REVIEW: This review will define morbid obesity and relationship between morbid obesity and heart failure syndromes. It will delve into unique challenges facing patients with dual diagnoses of heart failure and morbid obesity and examine the data that obesity should be a target in the treatment of heart failure. RECENT FINDINGS: Emerging literature has indicated the safety and efficacy of surgical weight loss in patients with heart failure. Furthermore, bariatric surgery with associated weight loss has been associated with improvements in heart failure symptoms and reverse remodeling on echocardiography. In patients with advanced heart failure, bariatric surgery has led to improvement in heart failure to obviate the need for cardiac transplantation or sufficient weight loss for cardiac transplant eligibility. In heart failurepatients who are morbidly obese, treatment of obesity is an effective therapeutic target with a myriad of potential benefits.
Entities:
Keywords:
Bariatric surgery; HFpEF; HFrEF; Metabolics of heart failure; Obesity
Authors: Sandeep R Das; Mark H Drazner; Daniel L Dries; Gloria L Vega; Harold G Stanek; Shuaib M Abdullah; Russell M Canham; Anne K Chung; David Leonard; Frank H Wians; James A de Lemos Journal: Circulation Date: 2005-10-04 Impact factor: 29.690
Authors: K Lietz; R John; E A Burke; J H Ankersmit; J D McCue; Y Naka; M C Oz; D M Mancini; N M Edwards Journal: Transplantation Date: 2001-07-27 Impact factor: 4.939
Authors: Joshua G Leichman; Erik B Wilson; Terry Scarborough; David Aguilar; Charles C Miller; Sherman Yu; Mohamed F Algahim; Manuel Reyes; Frank G Moody; Heinrich Taegtmeyer Journal: Am J Med Date: 2008-11 Impact factor: 4.965
Authors: Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Peter W F Wilson; Ramachandran S Vasan Journal: Circulation Date: 2004-02-10 Impact factor: 29.690
Authors: Satish Kenchaiah; Jane C Evans; Daniel Levy; Peter W F Wilson; Emelia J Benjamin; Martin G Larson; William B Kannel; Ramachandran S Vasan Journal: N Engl J Med Date: 2002-08-01 Impact factor: 91.245